PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML
Product details
Registration number: SIN16648P
Classification: Prescription Only
Active ingredients:
- CRM197 protein
- Pneumococcal polysaccharide serotype 1 (conjugate)
- Pneumococcal polysaccharide serotype 10A (conjugate)
- Pneumococcal polysaccharide serotype 11A (conjugate)
- Pneumococcal polysaccharide serotype 12F (conjugate)
- Pneumococcal polysaccharide serotype 14 (conjugate)
- Pneumococcal polysaccharide serotype 15B (conjugate)
- Pneumococcal polysaccharide serotype 18C (conjugate)
- Pneumococcal polysaccharide serotype 19A (conjugate)
- Pneumococcal polysaccharide serotype 19F (conjugate)
- Pneumococcal polysaccharide serotype 22F (conjugate)
- Pneumococcal polysaccharide serotype 23F (conjugate)
- Pneumococcal polysaccharide serotype 3 (conjugate)
- Pneumococcal polysaccharide serotype 33F (conjugate)
- Pneumococcal polysaccharide serotype 4 (conjugate)
- Pneumococcal polysaccharide serotype 5 (conjugate)
- Pneumococcal polysaccharide serotype 6A (conjugate)
- Pneumococcal polysaccharide serotype 6B (conjugate)
- Pneumococcal polysaccharide serotype 7F (conjugate)
- Pneumococcal polysaccharide serotype 8 (conjugate)
- Pneumococcal polysaccharide serotype 9V (conjugate)
Strength:
- Approx. 51 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 4.4 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
Dosage form: INJECTION, SUSPENSION
Route: INTRAMUSCULAR
Registrant: PFIZER PRIVATE LIMITED
ATC code: J07AL02
HSA approval date: 30 November 2022
Manufacturer(s): Pfizer Ireland Pharmaceuticals Unlimited Company
Manufacturing country/countries: IRELAND
What are the HSA registration number and classification for PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16648P
Classification: Prescription Only
What active ingredients and strength are recorded for PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- CRM197 protein
- Pneumococcal polysaccharide serotype 1 (conjugate)
- Pneumococcal polysaccharide serotype 10A (conjugate)
- Pneumococcal polysaccharide serotype 11A (conjugate)
- Pneumococcal polysaccharide serotype 12F (conjugate)
- Pneumococcal polysaccharide serotype 14 (conjugate)
- Pneumococcal polysaccharide serotype 15B (conjugate)
- Pneumococcal polysaccharide serotype 18C (conjugate)
- Pneumococcal polysaccharide serotype 19A (conjugate)
- Pneumococcal polysaccharide serotype 19F (conjugate)
- Pneumococcal polysaccharide serotype 22F (conjugate)
- Pneumococcal polysaccharide serotype 23F (conjugate)
- Pneumococcal polysaccharide serotype 3 (conjugate)
- Pneumococcal polysaccharide serotype 33F (conjugate)
- Pneumococcal polysaccharide serotype 4 (conjugate)
- Pneumococcal polysaccharide serotype 5 (conjugate)
- Pneumococcal polysaccharide serotype 6A (conjugate)
- Pneumococcal polysaccharide serotype 6B (conjugate)
- Pneumococcal polysaccharide serotype 7F (conjugate)
- Pneumococcal polysaccharide serotype 8 (conjugate)
- Pneumococcal polysaccharide serotype 9V (conjugate)
Strength:
- Approx. 51 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 4.4 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
- 2.2 μg/0.5ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SUSPENSION
Route: INTRAMUSCULAR
Who is the recorded registrant for PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML?
According to the HSA dataset updated 7 August 2026:
Registrant: PFIZER PRIVATE LIMITED
Which manufacturers and countries are listed for PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Pfizer Ireland Pharmaceuticals Unlimited Company
Manufacturing country/countries: IRELAND
Where can I look up PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16648P or the exact product name PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML. The general register link does not preselect this product.
What are the source dates for this PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this PREVENAR 20 SUSPENSION FOR INJECTION IN SINGLE-DOSE PRE-FILLED SYRINGE 0.5ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16648P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)